Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumorsJiaping Li, Yanhong Deng, Wei Jiang et al.|Journal of Translational Medicine|2020Cited by 39
<p>Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing</p>Chenlu Zhang, Yuhong Zhou, Yi Feng et al.|OncoTargets and Therapy|2020Cited by 15